Suppression of inducible nitric oxide synthase and cyclooxygenase-2 expression in raw 264.7 macrophages by sesquiterpene lactones

Journal of Toxicology and Environmental Health - Part A

Volumn 68, Issue 23-24, 2005, Pages 2119-2131

  Sang, Gyu Shin ^a   Jae, Ku Kang ^a   Kang, Ro Lee ^a   Hyang, Woo Lee ^a   Jeung, Whan Han ^a   Wahn, Soo Choi ^b  

^a Sungkyunkwan University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYSTEINE; ESTAFIATONE; GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; PROSTAGLANDIN E2; SESQUITERPENE LACTONE DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZALUZANIN C;

ALKYLATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG ISOLATION; ENZYME ACTIVATION; ENZYME INHIBITION; IC 50; MACROPHAGE ACTIVATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTERACEAE; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOCHONDRIA; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RNA, MESSENGER; SESQUITERPENES; TETRAZOLIUM SALTS; THIAZOLES;

AINSLIAEA; ANIMALIA;

EID: 28744434149     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390591009506     Document Type: Article

References (30)

1. Andrews, N. C., and Faller, D. V. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acid Res 19:2499.
2. Baeuerle, P. A., and Henkel, T. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
3. Barnes, P. J., and Karin, M. 1997. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-1071.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Chen, Z., Hagler, J., Palombella, V. J., Melandri, F., Scherer, D., Ballard, D., and Maniatis, T. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 9:1586-1597.
6. Crofford, L. J., Tan, B., McCarthy, C. J., and Hla, T. 1997. Involvement of nuclear factor-κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 40:226-236.
7. Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., and Needleman, P. 1990. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. 265:16737-16740.
8. Ghosh, S., May, M. J., and Kopp, E. B. 1998. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
9. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R. 1982. Analysis of nitrate, nitrite, and [15N]-nitrate in biological fluids. Anal. Biochem. 126:131-138.
10. Han, J. W., Lee, B. G., Kim, Y. K., Yoon, J. W., Jin, H. K., Hong, S., Lee, H. Y., Lee, K. R., and Lee, H. W. 2001. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-κB. Br. J. Pharmacol. 133:503-512.
11. Hong, J. T., Lee, M. K., Park, K. S., Jung, K. M., Lee, R. D., Jung, H. K., Park, K. L., Yang, K. J., and Chung, Y. S. 2002. Inhibitory effect of peroxisome proliferator-activated receptor gamma agonist on ochratoxin A-induced cytotoxicity and activation of transcription factors in cultured rat embryonic midbrain cells. J. Toxicol. Environ. Health A 65:407-418.
12. Kang, J. L., Go, Y. H., Hur, K. C., and Castranova, V. 2000. Silica-induced nuclear factor-kappaB activation: involvement of reactive oxygen species and protein tyrosine kinase activation. J. Toxicol. Environ. Health A 60:27-46.
13. Kang, J. L., Lee, H. S., Pack, I. S., Leonard, S., and Castranova, V. 2001. Iron tetrakis (n-methyl-4′-pyridyl) porphyrinato (FeTMPyP) is a potent scavenging antioxidant and an inhibitor of stimulant-induced NF-kappaB activation of raw 264.7 macrophages. J. Toxicol. Environ. Health A 64:291-310.
14. Kim, E. J., Jin, H. K., Kim, Y. K., Lee, H. Y., Lee, S. Y., Lee, K. R., Zee, O. P., Han, J. W., and Lee, H. W. 2001. Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-κB activation. Biochem. Pharmacol. 61:903-910.
15. Lee, K. M., Kang, B. S., Lee, H. L., Son, S. J., Hwang, S. H., Kim, D. S., Park, J. S., and Cho, H. J. 2004. Spinal NF-κB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur. J. Neurosci. 19:3375-3381.
16. MacMicking, J., Xie, Q. W., and Nathan, C. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
17. Michel, T., Xie, Q. W., and Nathan, C. 1995. Molecular biological analysis of nitric oxide synthases. In Methods in nitric oxide research, eds. M. Feelisch, and J. S. Stamler 161-175.
18. Moncada, S., Palmer, R. M. J., and Higgs, E. A. 1991. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
19. Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100:2417-2423.
20. Rao, K. M. K. 2000. Molecular mechanisms regulating iNOS expression in various cell types. J. Toxicol. Environ. Health B 3:27-58.
21. 2 formation. J. Biol. Chem. 271:31496-31501.
22. Rüngeler, P., Castro, V., Mora, G., Goren, N., Vichnewski, W., Pahl, H. L., Merfort, I., and Schmidt, T. J. 1999. Inhibition of transcription factor NF-κB by sesquiterpene lactones: A proposed molecular mechanism of action. Bioorg. Med. Chem. 7:2343-2352.
23. Sautebin, L. 2000. Prostaglandins and nitric oxide as molecular targets for antiimflammatory therapy. Fitoterapia 71:S48-S57.
24. Sautebin, L., Ialenti, A., Ianaro, A., and Di Rosa, M. 1998. Relationship between nitric oxide and prostaglandins in carrageenin pleurisy. Biochem. Pharmacol. 55:1113-1117.
25. Smith, W. L., Garavito, R. M., and Dewitt, D. L. 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271:33157-33160.
26. Szabo, C., and Thiemermann, C. 1995. Regulation of the expression of the inducible isoform of nitric oxide synthase. Adv. Pharmacol. 34:113-153.
27. Traenckner, E. B., Wilk, S., and Baeuerle, P. A. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of I-κBα that is still bound to NF-κB. EMBO J 13:5433-5441.
28. Wong, H. R., and Menendez, I. Y. 1999. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 262:375-380.
29. Xie, Q. W., Whishnant, R., and Nathan, C. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
30. Xie, Q. W., Kashiwabara, Y., and Nathan, C. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705-4708.